MEDICAL COLLEGE OF WISCONSIN

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1893-01-01

Employees: 5K

Market Cap: -

Website: http://www.mcw.edu

Clinical Trials

Autologous or Donor Stem Cell Transplantation in Treating Patients With Recurrent Non-Hodgkin's Lymphoma (BMT CTN 0202)

Phase 2

Terminated

Conditions: Recurrent Grade 1 Follicular Lymphoma
Recurrent Grade 2 Follicular Lymphoma
Recurrent Grade 3 Follicular Lymphoma
Follicular Lymphoma

Interventions: Drug: Cyclophosphamide and Rituximab
Drug: Filgrastim
Radiation: Chemotherapy or Radiation therapy
Drug: Non-myeloablative Conditioning regimen
Procedure: Autologous transplant
Procedure: Allogeneic transplant
Drug: Rituximab maintenance therapy
Drug: GVHD Prophylaxis

First Posted Date: 2004-11-10

Last Posted Date: 2023-01-05

Lead Sponsor: Medical College of Wisconsin

Target Recruit Count: 30

Registration Number: NCT00096460

Locations: 🇺🇸
Emory University, Atlanta, Georgia, United States
🇺🇸
Baylor University Medical Center, Dallas, Texas, United States
🇺🇸
University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania, United States

and more 27 locations

Gallium Nitrate in Treating Children With Brain Tumor, Neuroblastoma, Rhabdomyosarcoma, Non-Hodgkin's Lymphoma, or Refractory Solid Tumors

Phase 1

Completed

Conditions: Brain and Central Nervous System Tumors
Lymphoma
Neuroblastoma
Sarcoma
Unspecified Childhood Solid Tumor, Protocol Specific

First Posted Date: 2004-10-05

Last Posted Date: 2013-07-18

Lead Sponsor: Medical College of Wisconsin

Target Recruit Count: 3

Registration Number: NCT00002543

Locations: 🇺🇸
Boston Floating Hospital Infants and Children, Boston, Massachusetts, United States
🇺🇸
Marlene & Stewart Greenebaum Cancer Center, University of Maryland, Baltimore, Maryland, United States
🇺🇸
Medical College of Wisconsin, Milwaukee, Wisconsin, United States

Comparison of Fluconazole vs Voriconazole to Treat Fungal Infections for Blood and Marrow Transplants (BMT CTN 0101)

Phase 3

Completed

Conditions: Infection
Lymphoma
Leukemia

Interventions: Drug: Voriconazole
Drug: Fluconazole

First Posted Date: 2004-01-13

Last Posted Date: 2023-01-04

Lead Sponsor: Medical College of Wisconsin

Target Recruit Count: 600

Registration Number: NCT00075803

Locations: 🇺🇸
Hackensack University Medical Center, Hackensack, New Jersey, United States
🇺🇸
Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
🇺🇸
University of Pennsylvania Cancer Center, Philadelphia, Pennsylvania, United States

and more 30 locations

Peripheral Blood Stem Cell Transplant vs Bone Marrow Transplant in Individuals With Hematologic Cancers (BMT CTN 0201)

Phase 3

Completed

Conditions: Myelodysplastic-Myeloproliferative Diseases
Leukemia
Myeloproliferative Disorders

Interventions: Biological: Allogeneic bone marrow transplantation
Biological: Peripheral blood stem cell transplantation

First Posted Date: 2004-01-13

Last Posted Date: 2023-01-04

Lead Sponsor: Medical College of Wisconsin

Target Recruit Count: 551

Registration Number: NCT00075816

Locations: 🇺🇸
Emory University, Atlanta, Georgia, United States
🇺🇸
Loyola University, Maywood, Illinois, United States
🇺🇸
Hackensack University Medical Center Cancer Center, Hackensack, New Jersey, United States

and more 42 locations

Genomic Dissection of a QTL Affecting the Lipid Profile

Withdrawn

Conditions: Cardiovascular Diseases
Heart Diseases
Obesity
Hyperlipidemia, Familial Combined

First Posted Date: 2003-07-14

Last Posted Date: 2015-09-10

Lead Sponsor: Medical College of Wisconsin

Registration Number: NCT00064688

Genetics of CRP in Families With Myocardial Infarction

Completed

Conditions: Coronary Disease
Heart Diseases
Myocardial Infarction
Cardiovascular Diseases

First Posted Date: 2003-07-10

Last Posted Date: 2015-09-24

Lead Sponsor: Medical College of Wisconsin

Target Recruit Count: 1406

Registration Number: NCT00064519

Genes of Hypertension in African Americans

Completed

Conditions: Cardiovascular Diseases
Heart Diseases
Hypertension

First Posted Date: 2003-07-01

Last Posted Date: 2014-04-24

Lead Sponsor: Medical College of Wisconsin

Target Recruit Count: 5000

Registration Number: NCT00063505

Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma or Other B-cell Cancers

Phase 2

Conditions: Lymphoma
Multiple Myeloma and Plasma Cell Neoplasm

First Posted Date: 2003-04-18

Last Posted Date: 2014-01-06

Lead Sponsor: Medical College of Wisconsin

Target Recruit Count: 10

Registration Number: NCT00003163

Locations: 🇺🇸
Medical College of Wisconsin, Milwaukee, Wisconsin, United States

Light-Emitting Diode Therapy in Preventing Mucositis in Children Receiving Chemotherapy With or Without Radiation Therapy Before Bone Marrow Transplantation

Phase 2

Conditions: Leukemia
Myelodysplastic Syndromes
Myelodysplastic/Myeloproliferative Neoplasms
Neuroblastoma
Oral Complications
Ovarian Cancer
Pain
Sarcoma
Chronic Myeloproliferative Disorders
Multiple Myeloma and Plasma Cell Neoplasm

First Posted Date: 2003-01-27

Last Posted Date: 2013-09-20

Lead Sponsor: Medical College of Wisconsin

Target Recruit Count: 80

Registration Number: NCT00036712

Locations: 🇺🇸
Medical College of Wisconsin Cancer Center, Milwaukee, Wisconsin, United States

Photodynamic Therapy With Porfimer Sodium in Treating Patients With Refractory Brain Tumors

Phase 1

Conditions: Brain and Central Nervous System Tumors
Metastatic Cancer

First Posted Date: 2003-01-27

Last Posted Date: 2013-09-20

Lead Sponsor: Medical College of Wisconsin

Target Recruit Count: 24

Registration Number: NCT00002647

Locations: 🇺🇸
Midwest Children's Cancer Center at Children's Hospital of Wisconsin, Milwaukee, Wisconsin, United States
🇺🇸
Medical College of Wisconsin Cancer Center, Milwaukee, Wisconsin, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy